What Global Clinical Trial Data Sharing & Transparency Obligations (2026) requires
Sponsors must comply with increasing requirements for clinical trial data transparency, including registration, summary results posting (ClinicalTrials.gov, EudraCT, etc.), individual participant data (IPD) sharing policies, and redaction strategies for privacy. Many funders and journals now mandate data sharing plans, with timelines for posting results and mechanisms for controlled access to IPD.
Pillar: Medical & Healthcare · Authority: WHO, ICMJE, EMA, FDA · Version: 1.0.0 · Last updated:
Primary source: https://www.who.int/clinical-trials-registry-platform
SHA-256 integrity: c81045eb1667103f9452a92471b5de0df1e2842b6be431e55415b3bac415ca08
Primary Citations — 4 traced to source
- ICH E6(R3) Good Clinical Practice Guideline
- EU Clinical Trials Regulation (EU) No 536/2014
+ 2 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/global-clinical-trial-data-sharing-2026.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/global-clinical-trial-data-sharing-2026.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/global-clinical-trial-data-sharing-2026
- Back to registry: Browse all 10,090 compliance nodes